BRC Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$6.85M Buy
+41,075
New +$6.95M 1.16% 35
2016
Q1
Sell
-112,034
Closed -$18.2M 112
2015
Q4
$18.2M Buy
112,034
+1,839
+2% +$289K 2.67% 16
2015
Q3
$15.2M Sell
110,195
-3,051
-3% -$481K 2.35% 23
2015
Q2
$17.4M Buy
113,246
+1,268
+1% +$203K 2.4% 22
2015
Q1
$17.9M Sell
111,978
-10,766
-9% -$1.7M 2.48% 25
2014
Q4
$19.6M Buy
122,744
+18,755
+18% +$2.92M 2.65% 19
2014
Q3
$14.6M Buy
+103,989
New +$13.6M 2.22% 27
2014
Q2
Sell
-11,530
Closed -$1.42M 139
2014
Q1
$1.42M Sell
11,530
-356
-3% -$43.2K 0.22% 50
2013
Q4
$1.36M Sell
11,886
-18,289
-61% -$2.08M 0.22% 51
2013
Q3
$3.38M Sell
30,175
-447
-1% -$48.5K 0.51% 48
2013
Q2
$3.02M Buy
+30,622
New +$3.18M 0.54% 36

Other funds holding AMGN

BRC Investment Management's AMGN Position: Q3 2016 in Review

BRC Investment Management opened a new position in Amgen (AMGN) in Q3 2016: 41,075 shares worth $6.85M. The stake represents 1.16% of the portfolio and ranks #35 among its holdings. This is a return to the name: BRC Investment Management previously reported a position in AMGN as recently as Q4 2015.

BRC Investment Management first reported a position in AMGN in Q2 2013 and has held it in 11 quarters since. The position peaked at $19.6M in Q4 2014. 1,517 funds tracked by Wall St. Rank hold AMGN as of Q3 2016.

  • BRC Investment Management held 41,075 shares of Amgen worth $6.85M as of Q3 2016.
  • Amgen was a new BRC Investment Management position in Q3 2016.
  • Amgen made up 1.16% of BRC Investment Management's portfolio in Q3 2016, its #35 holding.
  • BRC Investment Management first reported a position in Amgen in Q2 2013 and has held it in 11 quarters since.
  • BRC Investment Management's Amgen position peaked at $19.6M in Q4 2014.
  • 1,517 funds tracked by Wall St. Rank held Amgen as of Q3 2016.

Based on BRC Investment Management's 13F filing for Q3 2016, filed 31 Oct 2016.